http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100472914-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1996-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100472914-B1 |
| titleOfInvention | Angiogenesis inhibitors |
| abstract | The present invention relates to an angiogenesis inhibitor containing cysteine protease inhibitory compounds. As preferred cysteine protease inhibiting compounds, an epoxy succinic acid compound, a peptide halohydrazide compound, a calpine inhibiting compound, a compound of the following general formula (I) and a compound of the following general formula (VI) can be used.n n n n n n n n Angiogenesis inhibitors of the present invention inhibit the formation of new blood vessels in living tissues, and thus, blood vessels observed in angiogenesis and diabetic retinopathy, prematurity retinopathy, retinal vein occlusion, senile discoidal macular degeneration, etc. Not only can be used as an excellent therapeutic or prophylactic agent of formation, but also as a prophylactic agent of tumor metastasis. |
| priorityDate | 1995-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 540.